Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data

BACKGROUND: Cutaneous squamous cell carcinoma (cSCC) is the second most common cancer worldwide with relatively low metastatic potential (2–5%). Developments in therapeutic options have highlighted the need to better identify high‐risk patients who could benefit from closer surveillance, adjuvant th...

Descripción completa

Detalles Bibliográficos
Autores principales: Venables, Zoe Claire, Tokez, Selin, Hollestein, Loes M., Mooyaart, Antien L., van den Bos, Renate Ruth, Rous, Brian, Leigh, Irene M., Nijsten, Tamar, Wakkee, Marlies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315012/
https://www.ncbi.nlm.nih.gov/pubmed/34862598
http://dx.doi.org/10.1111/bjd.20909

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315012/
https://www.ncbi.nlm.nih.gov/pubmed/34862598
http://dx.doi.org/10.1111/bjd.20909

Ejemplares similares